Comparative study to assess the quality of analgesia of bupivacaine and bupivacaine with dexmedetomidine in ultrasound-guided pectoral nerve block type I and II in breast surgeries

Background and Aims: Dexmedetomidine has been demonstrated to be safe and efficacious in prolonging the duration of peripheral nerve blocks. This study was designed to compare the duration, quality of postoperative analgesia, hemodynamic stability, and patient's satisfaction with addition of de...

Full description

Bibliographic Details
Main Authors: Shaiqa Manzoor, Rajeev Taneja, Nishant Sood, Arun Puri, Geeta Kadayaprath
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2018-01-01
Series:Journal of Anaesthesiology Clinical Pharmacology
Subjects:
Online Access:http://www.joacp.org/article.asp?issn=0970-9185;year=2018;volume=34;issue=2;spage=227;epage=231;aulast=Manzoor
_version_ 1819243308756500480
author Shaiqa Manzoor
Rajeev Taneja
Nishant Sood
Arun Puri
Geeta Kadayaprath
author_facet Shaiqa Manzoor
Rajeev Taneja
Nishant Sood
Arun Puri
Geeta Kadayaprath
author_sort Shaiqa Manzoor
collection DOAJ
description Background and Aims: Dexmedetomidine has been demonstrated to be safe and efficacious in prolonging the duration of peripheral nerve blocks. This study was designed to compare the duration, quality of postoperative analgesia, hemodynamic stability, and patient's satisfaction with addition of dexmedetomidine to bupivacaine versus plain bupivacaine in pectoral nerve block (Pecs) type I and II in breast surgeries. Material and Methods: This prospective randomized double-blind study was carried out in 60 American Society of Anesthesiologists grade I–III female patients, aged 18–70 years randomly allocated into two equal groups. Group A received 10 ml 0.25% bupivacaine for pecs I block and 20 ml 0.25% bupivacaine for pecs II block. Group B received 10 ml 0.25% bupivacaine with dexmedetomidine for pecs I block and 20 ml 0.25% bupivacaine with dexmedetomidine in pecs II block, keeping a total dose of dexmedetomidine of 1 μg/kg body weight and the volume constant in both the groups. Results: Numerical rating scores at rest and on abduction of arm were significantly lower in Group B. There was a 40% increase in duration of complete analgesia in dexmedetomidine group (1024.0 ± 124.9 min) compared to plain bupivacaine (726.4 ± 155.3 min; P < 0.001). Total consumption of injection diclofenac sodium in 24 h was 23% less in Group B (77.5 ± 13.6 mg) compared to Group A (100.0 ± 35.9 mg, P = 0.003). Patient satisfaction score was significantly better in dexmedetomidine group. No adverse effects were noted in either group. Conclusion: Dexmedetomidine as an adjunct to bupivacaine helps prolong the duration and improves the quality of postoperative analgesia in pecs I and II block without serious side effects.
first_indexed 2024-12-23T14:53:38Z
format Article
id doaj.art-c9d7ac9c80184e82ad3aea20f96d216a
institution Directory Open Access Journal
issn 0970-9185
language English
last_indexed 2024-12-23T14:53:38Z
publishDate 2018-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Journal of Anaesthesiology Clinical Pharmacology
spelling doaj.art-c9d7ac9c80184e82ad3aea20f96d216a2022-12-21T17:42:52ZengWolters Kluwer Medknow PublicationsJournal of Anaesthesiology Clinical Pharmacology0970-91852018-01-0134222723110.4103/joacp.JOACP_366_16Comparative study to assess the quality of analgesia of bupivacaine and bupivacaine with dexmedetomidine in ultrasound-guided pectoral nerve block type I and II in breast surgeriesShaiqa ManzoorRajeev TanejaNishant SoodArun PuriGeeta KadayaprathBackground and Aims: Dexmedetomidine has been demonstrated to be safe and efficacious in prolonging the duration of peripheral nerve blocks. This study was designed to compare the duration, quality of postoperative analgesia, hemodynamic stability, and patient's satisfaction with addition of dexmedetomidine to bupivacaine versus plain bupivacaine in pectoral nerve block (Pecs) type I and II in breast surgeries. Material and Methods: This prospective randomized double-blind study was carried out in 60 American Society of Anesthesiologists grade I–III female patients, aged 18–70 years randomly allocated into two equal groups. Group A received 10 ml 0.25% bupivacaine for pecs I block and 20 ml 0.25% bupivacaine for pecs II block. Group B received 10 ml 0.25% bupivacaine with dexmedetomidine for pecs I block and 20 ml 0.25% bupivacaine with dexmedetomidine in pecs II block, keeping a total dose of dexmedetomidine of 1 μg/kg body weight and the volume constant in both the groups. Results: Numerical rating scores at rest and on abduction of arm were significantly lower in Group B. There was a 40% increase in duration of complete analgesia in dexmedetomidine group (1024.0 ± 124.9 min) compared to plain bupivacaine (726.4 ± 155.3 min; P < 0.001). Total consumption of injection diclofenac sodium in 24 h was 23% less in Group B (77.5 ± 13.6 mg) compared to Group A (100.0 ± 35.9 mg, P = 0.003). Patient satisfaction score was significantly better in dexmedetomidine group. No adverse effects were noted in either group. Conclusion: Dexmedetomidine as an adjunct to bupivacaine helps prolong the duration and improves the quality of postoperative analgesia in pecs I and II block without serious side effects.http://www.joacp.org/article.asp?issn=0970-9185;year=2018;volume=34;issue=2;spage=227;epage=231;aulast=ManzoorBupivacainedexmedetomidinepectoral nerve blockultrasound
spellingShingle Shaiqa Manzoor
Rajeev Taneja
Nishant Sood
Arun Puri
Geeta Kadayaprath
Comparative study to assess the quality of analgesia of bupivacaine and bupivacaine with dexmedetomidine in ultrasound-guided pectoral nerve block type I and II in breast surgeries
Journal of Anaesthesiology Clinical Pharmacology
Bupivacaine
dexmedetomidine
pectoral nerve block
ultrasound
title Comparative study to assess the quality of analgesia of bupivacaine and bupivacaine with dexmedetomidine in ultrasound-guided pectoral nerve block type I and II in breast surgeries
title_full Comparative study to assess the quality of analgesia of bupivacaine and bupivacaine with dexmedetomidine in ultrasound-guided pectoral nerve block type I and II in breast surgeries
title_fullStr Comparative study to assess the quality of analgesia of bupivacaine and bupivacaine with dexmedetomidine in ultrasound-guided pectoral nerve block type I and II in breast surgeries
title_full_unstemmed Comparative study to assess the quality of analgesia of bupivacaine and bupivacaine with dexmedetomidine in ultrasound-guided pectoral nerve block type I and II in breast surgeries
title_short Comparative study to assess the quality of analgesia of bupivacaine and bupivacaine with dexmedetomidine in ultrasound-guided pectoral nerve block type I and II in breast surgeries
title_sort comparative study to assess the quality of analgesia of bupivacaine and bupivacaine with dexmedetomidine in ultrasound guided pectoral nerve block type i and ii in breast surgeries
topic Bupivacaine
dexmedetomidine
pectoral nerve block
ultrasound
url http://www.joacp.org/article.asp?issn=0970-9185;year=2018;volume=34;issue=2;spage=227;epage=231;aulast=Manzoor
work_keys_str_mv AT shaiqamanzoor comparativestudytoassessthequalityofanalgesiaofbupivacaineandbupivacainewithdexmedetomidineinultrasoundguidedpectoralnerveblocktypeiandiiinbreastsurgeries
AT rajeevtaneja comparativestudytoassessthequalityofanalgesiaofbupivacaineandbupivacainewithdexmedetomidineinultrasoundguidedpectoralnerveblocktypeiandiiinbreastsurgeries
AT nishantsood comparativestudytoassessthequalityofanalgesiaofbupivacaineandbupivacainewithdexmedetomidineinultrasoundguidedpectoralnerveblocktypeiandiiinbreastsurgeries
AT arunpuri comparativestudytoassessthequalityofanalgesiaofbupivacaineandbupivacainewithdexmedetomidineinultrasoundguidedpectoralnerveblocktypeiandiiinbreastsurgeries
AT geetakadayaprath comparativestudytoassessthequalityofanalgesiaofbupivacaineandbupivacainewithdexmedetomidineinultrasoundguidedpectoralnerveblocktypeiandiiinbreastsurgeries